Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study.

Jana TrebatickáZuzana HradečnáFrantišek BöhmerMagdaléna VavákováIveta WaczulíkováIveta GaraiovaJán LuhaIgor ŠkodáčekJán ŠubaZdeňka Ďuračková

Published in: Child and adolescent psychiatry and mental health (2017)

CDI scores were reduced in the Omega-3 group and the depression subgroup had greater improvement than the mixed depressive/anxiety group. An Omega-3 fatty acid rich fish oil emulsion may be an effective adjuvant supplement during the treatment of depressive disorders in children. Trial registration ISRCTN81655012.

Keyphrases

fatty acid
bipolar disorder
sleep quality
stress induced
phase iii
early stage
depressive symptoms
clinical trial
young adults
study protocol
randomized controlled trial
physical activity
phase ii
open label